1. Home
  2. DXCM vs GFS Comparison

DXCM vs GFS Comparison

Compare DXCM & GFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • GFS
  • Stock Information
  • Founded
  • DXCM 1999
  • GFS 2009
  • Country
  • DXCM United States
  • GFS United States
  • Employees
  • DXCM N/A
  • GFS N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • GFS Semiconductors
  • Sector
  • DXCM Health Care
  • GFS Technology
  • Exchange
  • DXCM Nasdaq
  • GFS Nasdaq
  • Market Cap
  • DXCM 28.0B
  • GFS 23.1B
  • IPO Year
  • DXCM 2005
  • GFS 2021
  • Fundamental
  • Price
  • DXCM $80.21
  • GFS $44.76
  • Analyst Decision
  • DXCM Buy
  • GFS Buy
  • Analyst Count
  • DXCM 17
  • GFS 15
  • Target Price
  • DXCM $98.00
  • GFS $51.07
  • AVG Volume (30 Days)
  • DXCM 3.4M
  • GFS 1.6M
  • Earning Date
  • DXCM 02-06-2025
  • GFS 02-11-2025
  • Dividend Yield
  • DXCM N/A
  • GFS N/A
  • EPS Growth
  • DXCM 83.21
  • GFS N/A
  • EPS
  • DXCM 1.67
  • GFS 1.32
  • Revenue
  • DXCM $3,954,000,000.00
  • GFS $6,774,000,000.00
  • Revenue This Year
  • DXCM $13.10
  • GFS N/A
  • Revenue Next Year
  • DXCM $14.74
  • GFS $8.66
  • P/E Ratio
  • DXCM $48.12
  • GFS $33.83
  • Revenue Growth
  • DXCM 16.19
  • GFS N/A
  • 52 Week Low
  • DXCM $62.34
  • GFS $35.85
  • 52 Week High
  • DXCM $142.00
  • GFS $62.61
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 57.98
  • GFS 54.76
  • Support Level
  • DXCM $74.50
  • GFS $40.50
  • Resistance Level
  • DXCM $80.83
  • GFS $44.80
  • Average True Range (ATR)
  • DXCM 2.41
  • GFS 1.53
  • MACD
  • DXCM -0.04
  • GFS -0.08
  • Stochastic Oscillator
  • DXCM 78.46
  • GFS 60.98

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About GFS GlobalFoundries Inc.

GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates. GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and employs about 12,000 people.

Share on Social Networks: